Cargando…
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is availab...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842516/ https://www.ncbi.nlm.nih.gov/pubmed/36660543 http://dx.doi.org/10.2147/CIA.S361519 |
_version_ | 1784870146326659072 |
---|---|
author | Tuft, Colin Matar, Elie Menczel Schrire, Zoe Grunstein, Ronald R Yee, Brendon J Hoyos, Camilla M |
author_facet | Tuft, Colin Matar, Elie Menczel Schrire, Zoe Grunstein, Ronald R Yee, Brendon J Hoyos, Camilla M |
author_sort | Tuft, Colin |
collection | PubMed |
description | Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population. |
format | Online Article Text |
id | pubmed-9842516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98425162023-01-18 Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults Tuft, Colin Matar, Elie Menczel Schrire, Zoe Grunstein, Ronald R Yee, Brendon J Hoyos, Camilla M Clin Interv Aging Review Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population. Dove 2023-01-12 /pmc/articles/PMC9842516/ /pubmed/36660543 http://dx.doi.org/10.2147/CIA.S361519 Text en © 2023 Tuft et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Tuft, Colin Matar, Elie Menczel Schrire, Zoe Grunstein, Ronald R Yee, Brendon J Hoyos, Camilla M Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title_full | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title_fullStr | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title_full_unstemmed | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title_short | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults |
title_sort | current insights into the risks of using melatonin as a treatment for sleep disorders in older adults |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842516/ https://www.ncbi.nlm.nih.gov/pubmed/36660543 http://dx.doi.org/10.2147/CIA.S361519 |
work_keys_str_mv | AT tuftcolin currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults AT matarelie currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults AT menczelschrirezoe currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults AT grunsteinronaldr currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults AT yeebrendonj currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults AT hoyoscamillam currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults |